189 related articles for article (PubMed ID: 12055317)
1. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
Munoz J; Derstine A; Gower BA
Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
[TBL] [Abstract][Full Text] [Related]
2. Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use.
Gower BA; Muñoz J; Desmond R; Hilario-Hailey T; Jiao X
Obesity (Silver Spring); 2006 Jun; 14(6):1046-55. PubMed ID: 16861610
[TBL] [Abstract][Full Text] [Related]
3. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
Gower BA; Nagy TR; Goran MI; Smith A; Kent E
J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
[TBL] [Abstract][Full Text] [Related]
4. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
Faria AN; Ribeiro Filho FF; Gouveia Ferreira SR; Zanella MT
Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
[TBL] [Abstract][Full Text] [Related]
5. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
Manns PJ; Williams DP; Snow CM; Wander RC
Am J Hum Biol; 2003; 15(1):91-100. PubMed ID: 12552583
[TBL] [Abstract][Full Text] [Related]
6. Relationships of insulin sensitivity with fatness and fitness and in older men and women.
Ouyang P; Sung J; Kelemen MD; Hees PS; DeRegis JR; Turner KL; Bacher AC; Stewart KJ
J Womens Health (Larchmt); 2004 Mar; 13(2):177-85. PubMed ID: 15072732
[TBL] [Abstract][Full Text] [Related]
7. Regional body fat distribution and metabolic profile in postmenopausal women.
Piché ME; Lapointe A; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J; Lemieux S
Metabolism; 2008 Aug; 57(8):1101-7. PubMed ID: 18640388
[TBL] [Abstract][Full Text] [Related]
8. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
Sørensen MB; Rosenfalck AM; Højgaard L; Ottesen B
Obes Res; 2001 Oct; 9(10):622-6. PubMed ID: 11595778
[TBL] [Abstract][Full Text] [Related]
9. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidaemia in obese but not in overweight postmenopausal women.
Aasen G; Fagertun H; Halse J
Scand J Clin Lab Invest; 2008; 68(3):204-11. PubMed ID: 18446527
[TBL] [Abstract][Full Text] [Related]
10. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women.
Thomas T; Burguera B; Melton LJ; Atkinson EJ; O'Fallon WM; Riggs BL; Khosla S
Metabolism; 2000 Oct; 49(10):1278-84. PubMed ID: 11079816
[TBL] [Abstract][Full Text] [Related]
11. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
Tousignant B; Faraj M; Conus F; Garrel D; Brochu M; Rabasa-Lhoret R; Coderre L
Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
Lindmark S; Lönn L; Wiklund U; Tufvesson M; Olsson T; Eriksson JW
Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
15. Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women.
Sites CK; Brochu M; Tchernof A; Poehlman ET
Metabolism; 2001 Jul; 50(7):835-40. PubMed ID: 11436191
[TBL] [Abstract][Full Text] [Related]
16. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
20. Relationships between plasma leptin levels and body composition parameters measured by different methods in postmenopausal women.
Jürimäe T; Sudi K; Jürimäe J; Payerl D; Rüütel K
Am J Hum Biol; 2003; 15(5):628-36. PubMed ID: 12953174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
